288 related articles for article (PubMed ID: 32442891)
1. Attitudes and knowledge about cannabis and cannabis-based therapies among US neurologists, nurses, and pharmacists.
Szaflarski M; McGoldrick P; Currens L; Blodgett D; Land H; Szaflarski JP; Segal E
Epilepsy Behav; 2020 Aug; 109():107102. PubMed ID: 32442891
[TBL] [Abstract][Full Text] [Related]
2. Cannabis Treatment in Children with Epilepsy: Practices of Canadian Neurologists.
DeGasperis SM; Webster R; Pohl D
Can J Neurol Sci; 2020 Jul; 47(4):511-518. PubMed ID: 32127067
[TBL] [Abstract][Full Text] [Related]
3. A cross-sectional survey exploring the knowledge, experiences and attitudes of Australian pharmacists toward medicinal cannabis.
Bawa Z; Saini B; McCartney D; Bedoya-Pérez M; McLachlan AJ; McGregor IS
Int J Clin Pharm; 2023 Apr; 45(2):375-386. PubMed ID: 36446995
[TBL] [Abstract][Full Text] [Related]
4. Survey of Pharmacists' Knowledge of Connecticut's Medical Cannabis Program.
Reece SM; Holle L; Mukherjee K
Cannabis Cannabinoid Res; 2021; 6(1):66-73. PubMed ID: 33614954
[No Abstract] [Full Text] [Related]
5. Neurologists' perspectives on medical cannabis for pediatric drug-resistant epilepsy in Canada: A qualitative interview study.
Elliott J; DeJean D; Potter BK; Coyle D; Clifford T; McCoy B; Wells GA
Seizure; 2020 May; 78():118-126. PubMed ID: 32361185
[TBL] [Abstract][Full Text] [Related]
6. Cannabis use for symptom relief in multiple sclerosis: A cross-sectional survey of webinar attendees in the US and Canada.
Hildebrand A; Minnier J; Cameron MH
Mult Scler Relat Disord; 2020 Feb; 38():101516. PubMed ID: 31855842
[TBL] [Abstract][Full Text] [Related]
7. [Survey of neurologists regarding their attitudes toward medicinal cannabis and the effects of evidence-based cannabis education].
Masataka Y; Ikeda T; Ando Y
Rinsho Shinkeigaku; 2019 Jul; 59(7):405-411. PubMed ID: 31243253
[TBL] [Abstract][Full Text] [Related]
8. The legal status of cannabis (marijuana) and cannabidiol (CBD) under U.S. law.
Mead A
Epilepsy Behav; 2017 May; 70(Pt B):288-291. PubMed ID: 28169144
[TBL] [Abstract][Full Text] [Related]
9. Use of cannabis and its products among patients in a tertiary epilepsy center: A cross-sectional survey.
Puteikis K; Mameniškienė R
Epilepsy Behav; 2020 Oct; 111():107214. PubMed ID: 32580133
[TBL] [Abstract][Full Text] [Related]
10. Knowledge of and attitudes toward epilepsy surgery among neurologists in Saudi Arabia.
Aljafen B; Alomar M; Abohamra N; Alanazy M; Al-Hussain F; Alhumayyd Z; Mohammad Y; Muayqil T
Neurosciences (Riyadh); 2020 Jan; 25(1):43-49. PubMed ID: 31982894
[TBL] [Abstract][Full Text] [Related]
11. Fewer specialists support using medical marijuana and CBD in treating epilepsy patients compared with other medical professionals and patients: result of Epilepsia's survey.
Mathern GW; Beninsig L; Nehlig A
Epilepsia; 2015 Jan; 56(1):1-6. PubMed ID: 25413126
[TBL] [Abstract][Full Text] [Related]
12. Marijuana use among patients with epilepsy at a tertiary care center.
Kerr A; Walston V; Wong VSS; Kellogg M; Ernst L
Epilepsy Behav; 2019 Aug; 97():144-148. PubMed ID: 31252269
[TBL] [Abstract][Full Text] [Related]
13. A survey of Wisconsin pharmacists about cannabinoid products: Are we ready to recommend?
Emmerling S; Martin B; Schmitz N
J Am Pharm Assoc (2003); 2021; 61(6):e71-e75. PubMed ID: 34456146
[TBL] [Abstract][Full Text] [Related]
14. Changes in Arkansans' attitudes toward pharmacist involvement and regulation of medical cannabis following its availability in Arkansas.
Hernandez M; Franks AM; Payakachat N
J Am Pharm Assoc (2003); 2023; 63(4):1131-1137.e4. PubMed ID: 37207711
[TBL] [Abstract][Full Text] [Related]
15. Knowledge and attitudes of Australian general practitioners towards medicinal cannabis: a cross-sectional survey.
Karanges EA; Suraev A; Elias N; Manocha R; McGregor IS
BMJ Open; 2018 Jul; 8(7):e022101. PubMed ID: 29970456
[TBL] [Abstract][Full Text] [Related]
16. Assessing the preparedness and future-readiness of Malaysian community pharmacists in Klang Valley regarding the use of medical marijuana.
Kuang FW; Farrukh MJ
BMC Health Serv Res; 2024 Apr; 24(1):524. PubMed ID: 38664704
[TBL] [Abstract][Full Text] [Related]
17. A survey of the attitudes, beliefs and knowledge about medical cannabis among primary care providers.
Philpot LM; Ebbert JO; Hurt RT
BMC Fam Pract; 2019 Jan; 20(1):17. PubMed ID: 30669979
[TBL] [Abstract][Full Text] [Related]
18. Assessment of education in a community hospital on healthcare providers' knowledge of and attitudes toward medical marijuana.
Meyers S; Gant K; Burmeister M
Curr Pharm Teach Learn; 2024 Jun; 16(6):396-403. PubMed ID: 38538449
[TBL] [Abstract][Full Text] [Related]
19. Medical Cannabis.
Ebbert JO; Scharf EL; Hurt RT
Mayo Clin Proc; 2018 Dec; 93(12):1842-1847. PubMed ID: 30522595
[TBL] [Abstract][Full Text] [Related]
20. A systematic review of medical students' and professionals' attitudes and knowledge regarding medical cannabis.
Weisman JM; Rodríguez M
J Cannabis Res; 2021 Oct; 3(1):47. PubMed ID: 34641976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
